ABSTRACT
BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) has a high risk of pancreatitis although the underlying mechanisms are unclear. Transient receptor potential vanilloid 1 (TRPV1) is a cation channel expressed on C and Adelta fibres of primary sensory neurons and is activated by low pH. TRPV1 activation causes release of inflammatory mediators that produce oedema and neutrophil infiltration. We previously demonstrated that neurogenic factors contribute to the pathogenesis of pancreatitis. Resiniferatoxin (RTX) is a TRPV1 agonist that, in high doses, defunctionalises C and Adelta fibres. When we discovered that the pH of radio-opaque contrast solutions used for ERCP was 6.9, we hypothesised that low pH may contribute to the development of contrast-induced pancreatitis via activation of TRPV1. METHODS: Rats underwent equal pressure pancreatic ductal injection of contrast solutions at varying pH with or without RTX. RESULTS: Contrast solution (pH 6.9) injected into the pancreatic duct caused a significant increase in pancreatic oedema, serum amylase, neutrophil infiltration, and histological damage. Solutions of pH 7.3 injected at equal pressure caused little damage. The severity of the pancreatitis was significantly increased by injection of solutions at pH 6.0. To determine if the effects of low pH were mediated by TRPV1, RTX was added to the contrast solutions. At pH levels of 6.0 and 6.9, RTX significantly reduced the severity of pancreatitis. CONCLUSIONS: Contrast solutions with low pH contribute to the development of pancreatitis through a TRPV1-dependent mechanism. It is possible that increasing the pH of contrast solution and/or adding an agent that inhibits primary sensory nerve activation may reduce the risk of post-ERCP pancreatitis.
Subject(s)
Cholangiopancreatography, Endoscopic Retrograde/adverse effects , Contrast Media/adverse effects , Pancreas/drug effects , Pancreatitis/drug therapy , Animals , Contrast Media/chemistry , Diterpenes/pharmacology , Hydrogen-Ion Concentration/drug effects , Male , Neurogenic Inflammation/complications , Neurons, Afferent/drug effects , Pancreatitis/chemically induced , Rats , Rats, Sprague-Dawley , Severity of Illness Index , TRPV Cation Channels/pharmacologyABSTRACT
OBJECTIVES: Acute hypercalcemia is a serious condition and represents a physician-surgical emergency: the difficulty in setting a precise diagnosis is due to several possibilities that can cause the condition. It is our purpose to critically evaluate the most actual schemes of treatment and the conditions that could favour the appearance of a hypercalcemic acute crisis. MATERIALS AND METHODS: A retrospective study was performed considering 1321 patients (638 primary HPT, 683 secondary or tertiary HPT) operated from 1975 to December 2002 for Primary, Secondary and Tertiary HPT. RESULTS: It should be noticed that out of 638 cases of Primary HPT this syndrome was present in 35 patients (Ca higher than 15 mg/dl): if you compare these cases with the hyperparathyroid population with calcium less than 15 mg/dl it is possible to observe that a double adenoma or a carcinoma were more frequently found in acute HPT, as the cystic appearance of the lesion. The weight of the adenoma and the PTH assay are strictly correlated with the appearance of this syndrome. The mortality rate is also higher (2.8% to 0.1%) than in the hyperparathyroid patient who underwent parathyroidectomy without hypercalcemic crisis. CONCLUSION: These characteristics suggest that an early operation is mandatory in the patients in whom such a possibility could be expected, before serious involvement of the cardiovascular, renal or neuromuscular system. We can point out the rarity of this syndrome in Secondary and Tertiary HPT: just one case in Secondary out of 683 patients operated on from 1975 until December 2002.
Subject(s)
Adenoma/surgery , Hyperparathyroidism , Parathyroid Neoplasms/surgery , Acute Disease , Diagnosis, Differential , Female , Humans , Hypercalcemia/etiology , Hyperparathyroidism/diagnosis , Hyperparathyroidism/mortality , Hyperparathyroidism/surgery , Hyperparathyroidism/therapy , Hyperparathyroidism, Secondary/surgery , Male , Middle Aged , Parathyroid Hormone/blood , Parathyroidectomy , Retrospective Studies , SyndromeABSTRACT
AIMS: To determine whether, in secondary and tertiary hyperparathyroidism (HPT), quick parathyroid hormone (PTH) assay can be used to prevent persistent or recurrent HPT. Another point was to determine, considering the PTH decrease, the cut-off point at which the operation could be considered well performed. METHODS: A retrospective study was performed evaluating all cases operated on since 1975 until 2002, 679 patients, and particularly the analysis of two groups of patients that underwent surgical treatment for secondary and tertiary HPT in the period 1995-2002. In the first group, (January 1995-October 1999) 207 (167 HPT II and 40 HPT III) neck explorations were performed without the aid of quick PTH assay; in the second group (November 1999-December 2002), 192 (153 HPT II and 39 HPT III) patients were operated on with blood samples for quick PTH. RESULTS: In the first group the percentage of success for secondary HPT was 93.8 versus 96.2 of the second group and 91.7 versus 94.2 for tertiary HPT. In reoperations the percentage of success was 72.7 in the first group and 87.5 in the second one. CONCLUSIONS: There are no substantial differences in persistences or recurrences between subtotal or total parathyroidectomy (PTx) with autotransplantation (AT). The choice of the gland to be left in the neck or transplanted in the forearm and the modalities of doing so are very important, considering the macroscopical and histological aspects. Intraoperative PTH monitoring is a useful aid during the first cervical exploration for secondary and tertiary HPT to prevent the development of persistent or recurrent HPT. The cut-off point for secondary HPT is 70% (in difficult cases with more than 2 assays, 75%) and for tertiary HPT 50% and 70% respectively.
Subject(s)
Hyperparathyroidism/surgery , Female , Humans , Hyperparathyroidism/blood , Hyperparathyroidism/classification , Male , Middle Aged , Parathyroid Hormone/blood , Retrospective StudiesABSTRACT
We examined whether the capsaicin vanilloid receptor-1 (VR1) mediates substance P (SP) release from primary sensory neurons in experimental pancreatitis. Pancreatitis was achieved by 12 hourly injections of caerulein (50 microg/kg ip) in mice. One group received capsazepine (100 micromol/kg sc), a competitive VR1 antagonist, at 4-h intervals. Neurokinin-1 receptor (NK1R) internalization in acinar cells, used as an index of endogenous SP release, was assessed by immunocytochemical quantification of NK1R endocytosis. The severity of pancreatitis was assessed by measurements of serum amylase, pancreatic myeloperoxidase (MPO) activity, and histological grading. Caerulein administration caused significant elevations in serum amylase and pancreatic MPO activity, produced histological evidence of pancreatitis, and caused a dramatic increase in NK1R endocytosis. Capsazepine treatment significantly reduced the level of NK1R endocytosis, and this was associated with similar reductions in pancreatic MPO activity and histological severity of pancreatitis. These results demonstrate that repeated caerulein stimulation causes experimental pancreatitis that is mediated in part by stimulation of VR1 on primary sensory neurons, resulting in endogenous SP release.
Subject(s)
Capsaicin/analogs & derivatives , Pancreatitis/metabolism , Receptors, Drug/physiology , Substance P/metabolism , Amylases/blood , Animals , Capsaicin/pharmacology , Endocytosis , Male , Mice , Mice, Inbred C57BL , Pancreas/drug effects , Pancreas/enzymology , Pancreas/pathology , Pancreas/physiopathology , Pancreatitis/pathology , Pancreatitis/physiopathology , Peroxidase/metabolism , Receptors, Neurokinin-1/metabolism , Severity of Illness Index , Substance P/antagonists & inhibitors , TRPV Cation ChannelsABSTRACT
The mechanism by which Clostridium difficile toxin A causes substance P (SP) release and subsequent inflammation in the rat ileum is unknown. Pretreatment with the vanilloid receptor subtype 1 (VR1) antagonist, capsazepine, before toxin A administration significantly inhibited toxin A-induced SP release and intestinal inflammation. Intraluminal administration of the VR1 agonist capsaicin caused intestinal inflammation similar to the effects of toxin A. Pretreatment with capsazepine before capsaicin administration also significantly inhibited capsaicin-induced intestinal inflammation. These results suggest that intraluminal toxin A causes SP release from primary sensory neurons via stimulation of VR1 receptors resulting in intestinal inflammation.
Subject(s)
Bacterial Toxins/pharmacology , Capsaicin/analogs & derivatives , Capsaicin/pharmacology , Enteritis/drug therapy , Enterotoxins/pharmacology , Ileum/drug effects , Receptors, Drug/agonists , Receptors, Drug/antagonists & inhibitors , Substance P/metabolism , Acute-Phase Reaction/chemically induced , Animals , Bacterial Toxins/isolation & purification , Capsaicin/therapeutic use , Clostridioides difficile/pathogenicity , Dose-Response Relationship, Drug , Drug Interactions , Endocytosis/physiology , Enteritis/chemically induced , Enteritis/pathology , Enterotoxins/isolation & purification , Ileum/blood supply , Ileum/enzymology , Ileum/microbiology , Ileum/surgery , Immunohistochemistry , Intestinal Secretions/drug effects , Intestinal Secretions/metabolism , Male , Neurogenic Inflammation/chemically induced , Neurons/drug effects , Neurons/immunology , Peroxidase/metabolism , Rats , Substance P/antagonists & inhibitors , Substance P/drug effects , Time FactorsABSTRACT
The agonist activity of substance P (SP) is a function of the C-terminal domain of the peptide. A C-terminal SP fragment (SP(6-11)) and analog (septide) and neurokinin A (NKA; a related tachykinin with a divergent N-terminal amino acid sequence) were found to be full neurokinin-1 receptor (NK-1R) agonists, but were not able to desensitize the receptor maximally as much as SP. Substance P caused 95.6 +/- 0.9% maximal desensitization of the NK-1R whereas SP(6-11), septide, and NKA(only)caused 74 +/- 3.5, 50.6 +/- 8, and 71.5 +/- 4.4% maximal desensitization, respectively (mean +/- SEM; P < 0.001 vs SP). When a series of SP C-terminal fragment peptides were tested for their NK-1R desensitizing activity, it was found that SP(5-11)and SP(6-11)caused significantly less maximal NK-1R desensitization than SP. SP N-terminal fragment peptides had no effect on the ability of SP(6-11)to compete with(3)H-SP binding, generate an IP(3)response, or cause NK-1R desensitization when tested with or without SP(6-11). SP, SP(6-11), septide, and NKA all maximally stimulated 8-9-fold increases in NK-1R phosphorylation. When attached to the C-terminal domain of SP responsible for NK-1R binding and agonism, the N-terminus of SP is responsible for 25-50% of homologous desensitization and this may occur via a mechanism other than NK-1R phosphorylation.
Subject(s)
Peptide Fragments/chemistry , Peptide Fragments/metabolism , Receptors, Neurokinin-1/metabolism , Substance P/chemistry , Substance P/metabolism , Animals , Cell Line, Transformed , Inositol 1,4,5-Trisphosphate/analysis , Kidney/cytology , Neurokinin A/pharmacology , Peptide Fragments/pharmacology , Phosphorylation , Protein Structure, Tertiary/physiology , Rats , Second Messenger Systems/physiology , Substance P/pharmacology , TransfectionABSTRACT
Clostridium difficile enteritis is caused by toxin A (TA) which stimulates substance P release and subsequent receptor activation. This receptor stimulation results in secretion, inflammation, and structural damage. However, it is unclear as to which subset of neurons is required to initiate substance P release following toxin stimulation. Five centimeter ileal segments were surgically denervated. After 10 days, three ileal loops were constructed in each rat: the denervated loop was injected intraluminally with 5 microg of TA and two intact loops were injected with TA or vehicle, respectively. Ileal secretion, myeloperoxidase activity, and histology were then assessed. Denervated ileal loops injected with TA had a 75% reduction in ileal secretion (P < 0.001), 92% reduction in myeloperoxidase activity (P < 0.01) and 96% reduction in histologic damage (P < 0.001) compared to innervated loops. There were no significant differences between the denervated loops injected with TA and those injected with vehicle. Extrinsic surgical denervation results in protection of ileal loops from TA enteritis. Furthermore, these results exclude the participation of intrinsic enteric nerves in TA-induced ileal damage. Finally, this suggests that extrinsic primary sensory neurons mediate the effects of intraluminal TA in the ileum.
Subject(s)
Autonomic Denervation , Bacterial Toxins/pharmacology , Clostridioides difficile , Enterocolitis, Pseudomembranous/surgery , Enterotoxins/pharmacology , Animals , Enteric Nervous System/microbiology , Enteric Nervous System/surgery , Enterocolitis, Pseudomembranous/chemically induced , Enterocolitis, Pseudomembranous/prevention & control , Ileum/enzymology , Ileum/innervation , Ileum/microbiology , Peroxidase/metabolism , Rats , Rats, Sprague-Dawley , Substance P/metabolismABSTRACT
A rat kidney epithelial cell line expressing the rat neurokinin-1 receptor (NK-1 R) was used to investigate the relationship between receptor phosphorylation and desensitization. Substance P (SP) maximally stimulated cellular inositol 1,4,5-trisphosphate (IP3) production 14-fold within 3 s, after which cellular IP3 levels rapidly diminished to near basal levels in the continuing presence of SP. SP also caused concentration-dependent phosphorylation of the NK-1R, and this effect was blocked by a receptor antagonist. Stimulation with 100 nM SP for as little as 2 s resulted in 90% desensitization of the receptor to restimulation by SP, and near-maximal receptor phosphorylation was observed at 5 s. Receptor desensitization was not affected by agents that affect protein kinase A. Phorbol 12-myristate 13-acetate (PMA) also caused phosphorylation and desensitization of the receptor but with slower kinetics and to a lesser extent than SP. PMA- but not SP-induced NK-1 R desensitization and phosphorylation were abolished by the protein kinase C inhibitor bisindolylmaleimide 1. The concentration-response curves for SP-stimulated IP3 signaling and desensitization were similar, but the curve for NK-1R phosphorylation was shifted to the right and was steeper, suggesting that the relationship between desensitization and phosphorylation is complex. These results show that both rapid homologous and rapid heterologous NK-1R desensitizations may be mediated by receptor phosphorylation but occur via distinct mechanisms with different kinetics and efficacies.
Subject(s)
Epithelial Cells/metabolism , Gene Expression , Receptors, Neurokinin-1/drug effects , Receptors, Neurokinin-1/genetics , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Animals , Cell Line, Transformed , Enzyme Inhibitors/pharmacology , Immunosorbent Techniques , Indoles/pharmacology , Inositol 1,4,5-Trisphosphate/metabolism , Kidney , Kinetics , Maleimides/pharmacology , Neurokinin-1 Receptor Antagonists , Phosphorylation , Protein Kinase C/antagonists & inhibitors , Rats , Signal Transduction/drug effects , Substance P/pharmacology , Tetradecanoylphorbol Acetate/pharmacologyABSTRACT
125I-monitor peptide binding was performed using frozen sections of the rat liver and gut and visualized using autoradiography. Saturable binding was observed in unidentified single cells in the liver and in the mucosa of the small intestine. Epidermal growth factor (EGF) and GTPgammaS did not inhibit 125I-monitor peptide binding indicating that the binding sites are not EGF receptors or G protein-coupled receptors. The liver binding site exhibited an affinity 3.7-4.4-fold higher than those in the small intestine. It has been established that intraluminal monitor peptide releases cholecystokinin from the small intestine. The present results indicate that monitor peptide may also have liver associated functions.
Subject(s)
Growth Substances/metabolism , Intercellular Signaling Peptides and Proteins , Intestine, Small/chemistry , Liver/chemistry , Receptors, Peptide/isolation & purification , Animals , Autoradiography , Binding, Competitive , Cholecystokinin/metabolism , Cloning, Molecular , Epidermal Growth Factor/metabolism , Gastrointestinal Hormones/genetics , Gastrointestinal Hormones/metabolism , Growth Substances/genetics , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Iodine Radioisotopes , Pancreatic Hormones/genetics , Pancreatic Hormones/metabolism , Protein Binding , Rats , Trypsin Inhibitor, Kazal Pancreatic/genetics , Trypsin Inhibitor, Kazal Pancreatic/metabolismABSTRACT
The secretin receptor is a member of a structurally distinct class of G protein-coupled receptors designated as Class II. The molecular mechanisms of secretin receptor signal termination are unknown. Using transiently transfected HEK 293 cells expressing the secretin receptor, we investigated its mechanisms of desensitization. Binding of [125I]-secretin to plasma membranes of receptor-expressing cells was specific, with a Kd of 2 nM. Secretin evoked an increase in cellular cAMP with an EC50 of 0.4 nM. The response was maximal by 20 min and desensitized rapidly and completely. Immunoprecipitation of a functional, N-terminal epitope-tagged secretin receptor was used to demonstrate agonist-dependent receptor phosphorylation, with an EC50 of 14 nM. Pretreatment with protein kinase A or C inhibitors failed to alter secretin-stimulated cAMP accumulation. G protein-coupled receptor kinases (GRKs) are known to be involved in the desensitization of Class I G protein-coupled receptors; therefore, the effect of cotransfection of GRKs on secretin-stimulated cAMP signaling and phosphorylation was evaluated. GRKs 2 and 5 were the most potent at augmenting desensitization, causing a 40% reduction in the maximal cAMP response to secretin. GRK 5 also caused a shift in the EC50 to the right (p < 0.05). GRK 4 and GRK 6 did not alter dose-dependent signaling, and GRK 3 was intermediate in effect. Receptor phosphorylation correlated with desensitization for each GRK studied, whereas second messenger-dependent kinase phosphorylation appeared to be less important in secretin receptor signal termination. We demonstrate agonist-dependent secretin receptor phosphorylation coincident with profound receptor desensitization of the signaling function in HEK 293 cells, suggesting a role for receptor phosphorylation in this paradigm. Although GRK activity appears important in secretin receptor desensitization in HEK 293 cells, protein kinases A and C appear to play only a minor role. These results demonstrate that the GRK-arrestin system regulates Class II G protein-coupled receptors.
Subject(s)
GTP-Binding Proteins/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Gastrointestinal Hormone/metabolism , Secretin/metabolism , Cell Line , Humans , Phosphorylation , Precipitin Tests , Receptors, G-Protein-Coupled , Receptors, Gastrointestinal Hormone/agonists , Second Messenger Systems , Signal Transduction , Substrate SpecificityABSTRACT
Gastrin-like immunoreactive peptides were extracted from the gastric antrum of the American alligator (Alligator mississippiensis) and purified by fractionation using C18 Sep-Paks, Sephadex G-50, pH stable C8 reversed-phase HPLC, and C18 reversed-phase HPLC. Three major immunoreactive peaks were purified and found to correspond to 49, 45, and 34 residue peptides by microsequence analysis. The amino acid sequence of the largest peptide was DWLASLSQDQ KHLISKFLPH IYGELAN QEN YWQEDDALHD HDYPGWMDF-amide. The two smaller peptides corresponded to carboxyl-terminal 45 and 34 residue fragments of the 49 residue peptide. The putative proteolysis of the 49 residue peptide to the two shorter peptides occurs at cleavage sites that are unusual in biosynthetic processing. Mass spectral analysis confirmed the molecular weights that were predicted from the amino acid sequences, thus revealing the absence of any post-translational modifications, such as sulfation. Although the three alligator gastrins resemble mammalian cholecystokinin in having a tyrosine residue in the seventh position from the carboxyl terminus, this tyrosine is apparently nonsulfated as in turtle gastrin. When tested by radioreceptor assay, a synthetic replicate of alligator gastrin-49 exhibited a gastrin-like pattern of biological activity on mammalian CCK-A and CCK-B receptors. Comparison of the amino acid sequences of known peptides revealed that alligator gastrin is most similar to turtle gastrin (76% identical), followed by frog gastrin (51% identical), chicken gastrin (49% identical), and human gastrin (12% identical). These similarities closely reflect vertebrate phylogeny and support the hypothesis that functionally distinct gastrins evolved from CCK in early tetrapods. However, gastrin evolved via different mechanisms in the mammalian lineage (mechanism unknown) versus the amphibian and reptilian/avian lineages, in which two different single nucleotide base changes can account for the separate evolution of amphibian gastrin and reptilian/avian gastrin.
Subject(s)
Alligators and Crocodiles , Gastrins/chemistry , Gastrins/metabolism , Receptors, Cholecystokinin/metabolism , Amino Acid Sequence , Animals , Chromatography, Gel , Chromatography, High Pressure Liquid , Gastrins/isolation & purification , Humans , Mass Spectrometry , Molecular Sequence Data , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Pyloric Antrum/chemistry , Radioligand Assay , Receptor, Cholecystokinin A , Receptor, Cholecystokinin B , Sequence Analysis , Sequence HomologyABSTRACT
This study characterizes the location and subtype of peptide YY (PYY) receptors in rat and rabbit kidney and the effect of PYY on renal function and renal hemodynamics in rats. Receptor autoradiography performed on kidney sections revealed a dense concentration of specific high-affinity binding sites [dissociation constant (Kd) = 0.7 +/- 0.1 nM] in the papilla of the rat, as well as cortical and papillary binding in the rabbit (papilla, Kd = 1.6 +/- 0.6 nM) and some medullary binding in both species. In the rat papilla, neuropeptide Y (NPY) and the Y1 agonist [Leu31,Pro34]NPY competed with PYY for binding (Kd = 1.1 +/- 0.4 nM and 1.6 +/- 0.5 nM, respectively), but NPY-(13-36) (Y2 agonist) and pancreatic polypeptide (PP, Y4 agonist) were without effect, demonstrating that the PYY receptor in the rat papilla is of the Y1 subtype. In the rabbit papilla, NPY and NPY-(13-36) competed with PYY (Kd = 0.5 +/- 0.1 and 3.1 +/- 0.6 nM, respectively), but [Leu31,Pro34]NPY and PP were without effect, evidence that the PYY receptor in the rabbit papilla is of the Y2 subtype. Infusion of PYY into rats (47 pmol x kg(-1) x min[-1]) increased mean arterial pressure (103 +/- 6 to 123 +/- 8 mmHg) and decreased renal plasma flow (13 +/- 1.8 to 8.4 +/- 2.1 ml/min) but produced no significant change in glomerular filtration rate or sodium excretion. Injection of PYY or angiotensin II directly into the renal artery caused a dose-related vasoconstriction, which was less intense but of longer duration for PYY than for angiotensin II. These results show that receptors for PYY are widely distributed in the kidney and that exogenously administered PYY causes renal vasoconstriction and may influence renal sodium excretion.
Subject(s)
Kidney/physiology , Receptors, Gastrointestinal Hormone/metabolism , Renal Circulation/physiology , Animals , Female , Hemodynamics/drug effects , Hemodynamics/physiology , Kidney/drug effects , Kidney/metabolism , Male , Peptide YY/pharmacology , Rabbits , Rats , Rats, Sprague-Dawley , Receptors, Gastrointestinal Hormone/classification , Renal Circulation/drug effects , Tissue DistributionABSTRACT
Pancreatic polypeptide (PP) is a regulatory peptide that modulates gastrointestinal function. Previously we demonstrated PP receptors in the brainstem and interpeduncular nucleus, and the PP receptors in the brainstem appear to modulate gastric motility and pancreatic exocrine secretion. The purpose of this study is to extend our understanding of the distribution of PP receptors in the rat brain in order to determine the systems that are potentially modulated by PP. Rat brains were studied using 125I-PP receptor autoradiography on cryostat sections of the entire brain cut in three planes (horizontal, sagittal, and coronal). Brain regions exhibiting PP binding sites were confirmed when identified in all three planes of section. Saturable PP binding was identified in the hypothalamus (arcuate and paraventricular n), the rostral forebrain (medial preoptic area, anterior olfactory nucleus, islands of Calleja, the dorsal endopiriform n, piriform cortex, and the bed n of the stria terminalis), medial amygdaloid n; the thalamus (anteromedial thal. n; reuniens thal. n; and paraventricular thal n), the interpeduncular red nucleus, substantia nigra, parabrachial n; locus coeruleus, mesencephalic trigeminal n, dorsal motor n of the vagus, the n solitary tract, and the area postrema. We conclude that PP receptors are distributed widely throughout the rat brain. The distribution of many of these PP binding sites corresponds to brain regions regulating digestion and autonomic function. We speculate, based on the patterns of binding in the olfactory and limbic systems, that PP receptors might be involved in positive reinforcement of ingestion behavioral as well as modulation of gastrointestinal function.
Subject(s)
Brain/metabolism , Receptors, Gastrointestinal Hormone/metabolism , Animals , Autoradiography , Male , Radioligand Assay , Rats , Rats, Sprague-DawleyABSTRACT
Autoradiographic analysis of radioligand binding was used to localize and characterize cholecystokinin (CCK) receptors expressed in the stomach and gallbladder of the American alligator (Alligator mississippiensis). Alligator gallbladder smooth muscle expresses a CCK-A receptor subtype, and stomach oxyntic mucosa expresses a distinct receptor subtype, termed CCK-B/X because of its similarities to both CCK-B and CCK-X receptors. Both the gallbladder and the stomach binding sites have very low affinities for a panel of nonpeptide receptor agonists and antagonists that are selective for mammalian CCK-A and CCK-B receptors. These results suggest that CCK receptor subtypes diverged from the ancestral CCK-X receptor in an early amniote, prior to the divergence of mammals and reptiles in vertebrate phylogeny, and that CCK-A receptors may have evolved before CCK-B receptors. Our findings support the hypothesis that the evolution of gastrin preceded the evolution of two separate CCK receptor subtypes.
Subject(s)
Alligators and Crocodiles/metabolism , Cholecystokinin/metabolism , Gallbladder/metabolism , Gastric Mucosa/metabolism , Peptide Fragments/metabolism , Receptors, Cholecystokinin/metabolism , Amino Acid Sequence , Animals , Autoradiography , Binding, Competitive , Cholecystokinin/analysis , Cholecystokinin/chemistry , Densitometry , Gallbladder/anatomy & histology , Gastrins/chemistry , Gastrins/genetics , Humans , Iodine Radioisotopes , Muscle, Smooth/metabolism , Parietal Cells, Gastric/metabolism , Peptide Fragments/analysis , Peptide Fragments/chemistry , Phylogeny , Radioligand Assay , Receptor, Cholecystokinin A , Receptor, Cholecystokinin B , Receptors, Cholecystokinin/agonists , Receptors, Cholecystokinin/antagonists & inhibitors , Receptors, Cholecystokinin/chemistry , Stomach/anatomy & histologyABSTRACT
Bombesin's influence on gastric vagal afferent discharge (GVAD) was studied in urethan-anesthetized rats. Vehicle and peptides were injected intravenously at 30-min intervals. Cholecystokinin (CCK; 300 pmol) and bombesin (300 pmol) increased ongoing multiunit GVAD by 153 +/- 59 and 162 +/- 37%, respectively; similar increases were induced by a second injection of bombesin and CCK. The bombesin antagonist, ICI-216140, prevented bombesin-induced increase in GVAD, whereas the CCK response was not influenced. The CCK-A receptor antagonist devazepide reduced the activation of GVAD induced by bombesin from 107 +/- 11 to 63 +/- 6%, while abolishing the CCK response. Devazepide given alone or in combination with ICI-216140 did not modify gastric distension (3 ml)-induced increase in GVAD. Of 22 single units that were activated by gastric load (4 ml), 17 and 20 units responded also to bombesin (620 pmol) and CCK (870 pmol), respectively. Of the nine units that did not respond to gastric load, eight had an increase in GVAD induced by both bombesin and CCK. There was no specific binding of 125I-labeled [Tyr4]bombesin on cervical vagus, either intact or 24 h after ligation. These data suggest that intravenous bombesin-induced stimulation of GVAD is indirect and initially mediated through specific receptor activation influencing gastric smooth muscle and the release of CCK.
Subject(s)
Bombesin/pharmacology , Neurons, Afferent/physiology , Stomach/innervation , Vagus Nerve/physiology , Animals , Bombesin/antagonists & inhibitors , Catheterization , Cholecystokinin/pharmacology , Electrophysiology , Injections, Intravenous , Male , Neurons, Afferent/drug effects , Rats , Rats, Sprague-Dawley , Sodium Chloride/pharmacology , Stomach/physiology , Vagus Nerve/cytology , Vagus Nerve/drug effectsABSTRACT
BACKGROUND & AIMS: Nerves have been suggested to mediate the effects of bacterial toxins in intestinal diseases. However, the mechanisms involved are unknown. This study examined endogenous substance P (SP) activation of the substance P receptor (SPR) on enteric neurons in the rat ileum after exposure to intraluminal Clostridium difficile toxin A. METHODS: After intraluminal injection of toxin A in ileal loops, tissue was examined for pathological changes by histology and for SPR activation by immunocytochemical analysis of SP-induced SPR endocytosis. RESULTS: After toxin A administration, > 70% of enteric neurons showed SPR endocytosis and became swollen with thickened dendrites. In contrast, SPRs in control rats were largely confined to the plasma membrane. Rats denervated of primary afferent fibers with neonatal capsaicin injection and animals pretreated with a nonpeptide SPR antagonist showed few endosomal SPRs, and the pathological inflammatory effects of toxin A were ablated. CONCLUSIONS: Intraluminal toxin A causes the release of SP from primary afferent neurons: this endogenous SP then acts on enteric neurons in the submucosal and myenteric plexuses. SP is the primary mediator of an axon reflex mediating neurogenic inflammation in the intestine. SPR blockade may prove to be a novel therapy used to prevent intestinal inflammation.
Subject(s)
Bacterial Toxins , Clostridioides difficile/pathogenicity , Enterotoxins/toxicity , Ileum/drug effects , Neurons/drug effects , Receptors, Neurokinin-1/drug effects , Substance P/physiology , Animals , Capsaicin/pharmacology , Female , Ileum/chemistry , Ileum/innervation , Male , Rats , Rats, Sprague-Dawley , Receptors, Neurokinin-1/analysis , Receptors, Neurokinin-1/immunologyABSTRACT
In rat tongue, neurons containing substance P terminate in connective tissue, in taste buds, and in lingual epithelium surrounding taste buds in fungiform, foliate and circumvallate papillae. Although many functions have been attributed to these neurons, virtually nothing is known about their physiological function. As a step towards this end, immunocytochemical methods were used to identify the NK-1 receptors (SPR) in rat tongue. SPR-IR was found in the basolateral membranes of taste cells in fungiform, circumvallate and foliate papillae. SPR-IR was not found in the dorsal epithelium or in any structure that could be clearly identified as a neuron. SPR-IR was also found in von Ebner's glands in circumvallate and foliate papillae and in blood vessels in connective tissue in all three papillae. These data suggest that substance P may play a role in taste and/or in oral pain.
Subject(s)
Receptors, Neurokinin-1/metabolism , Substance P/metabolism , Tongue/chemistry , Amino Acid Sequence , Animals , Antibodies/immunology , Antibodies/metabolism , Immunohistochemistry , Male , Microscopy, Fluorescence , Molecular Sequence Data , Rats , Rats, Sprague-Dawley , Receptors, Neurokinin-1/chemistry , Receptors, Neurokinin-1/immunology , Taste/physiology , Taste Buds/chemistry , Taste Buds/physiology , Tongue/cytologyABSTRACT
The characterization and distribution of cholecystokinin (CCK)/gastrin binding sites were determined in the goldfish central nervous system (CNS). Binding of 125I-sulfated CCK octapeptide (125I-CCK-8s) in tissue sections was found to be saturable, reversible, time dependent, and displaceable by CCK/gastrin-like peptides. Analysis of saturable equilibrium binding revealed a high-affinity binding site (dissociation constant of 0.706 +/- 0.188 nM), which also displayed high affinity for gastrin-17s and caerulein. Lower affinities were observed for the nonsulfated forms of CCK-8 and gastrin-17. These findings suggest that a single primitive CCK/gastrin receptor exists in the goldfish CNS. The distribution of CCK/gastrin binding sites in the goldfish brain and pituitary revealed high densities within the telencephalon and preoptic hypothalamus, as well as within hypothalamic nuclei associated with the brain feeding center. High densities of binding sites were also localized within the midbrain tegmentum and optic tectum of the midbrain, the facial lobe and vagal lobe of the hindbrain, and within the pituitary pars distalis. Overall, these findings support previous studies that indicate that CCK/gastrin-like peptides play a role in the central regulation of feeding behavior and pituitary hormone secretion in fish.
Subject(s)
Brain/metabolism , Cholecystokinin/metabolism , Goldfish/metabolism , Pituitary Gland/metabolism , Animals , Binding Sites , Binding, Competitive , Female , Gastrins/metabolism , Male , Sincalide/analogs & derivatives , Sincalide/metabolism , Tissue DistributionABSTRACT
These studies of a model liver cell line evaluate the mechanisms responsible for regulated release of K+ ions during metabolic stress. Metabolic inhibition of HTC hepatoma cells by exposure to 2, 4-dinitrophenol (50 microM) and 2-deoxy-D-glucose (10 mM) stimulated outward currents carried by K+ of 974 +/- 75 pA at 0 mV (n = 20, p < 0.001). Currents were inhibited by chelation of intracellular Ca2+ or exposure to apamin (50 nM), an inhibitor of SKCa channels. In cell-attached recordings from intact cells, removal of metabolic substrates (25/28 cells) or exposure to metabolic inhibitors (32/40 cells) opened K+-selective channels with a conductance of 6.5 +/- 0. 2 pS. Channels had an open probability of 0.31 +/- 0.08 and opened in bursts averaging 3.55 +/- 0.27 ms in duration (n = 6). Metabolic stress was associated with rapid translocation of the alpha isoform of protein kinase C (PKCalpha) from cytosol to membrane; and down-regulation of PKCalpha by phorbol esters or exposure to the PKC inhibitor chelerythrine (10 microM) each inhibited currents. Moreover, intracellular perfusion with purified PKCalpha activated currents in a Ca2+- and concentration-dependent manner. These findings indicate that metabolic stress leads to opening of apamin-sensitive SKCa channels in hepatoma cells through a Ca2+- and PKC-dependent mechanism and suggest that PKCalpha may be selectively involved in the response. This mechanism functionally couples the metabolic state of cells to membrane K+ permeability and represents a potential target for modification of liver injury associated with ischemia and preservation.
Subject(s)
Calcium/metabolism , Ion Channel Gating , Isoenzymes/metabolism , Liver/metabolism , Potassium Channels/metabolism , Potassium/metabolism , Protein Kinase C/metabolism , 2,4-Dinitrophenol , Adenosine Triphosphate/metabolism , Amino Acid Sequence , Animals , Biological Transport , Deoxyglucose/pharmacology , Dinitrophenols/pharmacology , Electric Conductivity , Electric Impedance , Enzyme Inhibitors , Isoenzymes/antagonists & inhibitors , Liver/cytology , Liver/drug effects , Molecular Sequence Data , Protein Kinase C/antagonists & inhibitors , Protein Kinase C-alpha , Protein Kinases/metabolism , Rats , Tumor Cells, CulturedABSTRACT
Recent pharmacological and biochemical studies have suggested that there may be more than one molecular form of the neurokinin-1 receptor (NK-1), a long and short isoform differing in the length of their cytoplasmic carboxyl-terminal tails, but no definitive evidence of the existence of such NK-1 receptor isoforms in tissue has been presented. To examine whether these different isoforms are expressed in vivo we have compared the distribution of high affinity substance P (SP) binding sites (visualized by autoradiography with [125I]SP), with the distribution of the C-terminal epitope of the full length receptor (visualized with a specific antibody against the extreme C-terminal sequence). The former method labels both long and short forms of the NK-1 receptor, while the latter labels only the long form of the protein. In the rat there is a close correspondence of [125I]SP binding and NK-1 immunoreactivity in the striatum, suggesting that the long isoform predominates in this tissue. In the parotid and submaxillary gland, there are very high levels of [125I]SP binding but only low levels of NK-1 immunoreactivity, suggesting that expression of the short form predominates in these tissues. These results imply that different tissues express different ratios of the two isoforms of the NK-1 receptor. This differential expression provides the theoretical basis for tissue specific pharmacological targeting of NK-1 receptors.